Symposium participants received a comprehensive review of cellular medicine, review current techniques, and learn various applications and protocols for delivering stem cell treatments to patients that address a range of health and aesthetic indications. The field of regenerative medicine is expanding at an exponential rate. The number of clinical trials employing adult stem cells is now in the thousands.
EVENT / what it’s all about
SPEAKERS / meet the experts
AGENDA / event schedule
Dr. Eduardo Mazzaro
08:00 - 09:00
Cutting Edge Concepts in the Practice of Regenerative Medicine
Understanding aging as a platform for tissue regeneration. The prevailing belief in anti-aging medicine is that the rate of aging in an individual depends on the wear vs. regeneration ratio in any given tissue. Not even the body’s stem cell niches are exempt from this relationship, as stem cells age and their regenerative and modulating capacity decrease.
In her dissertation, Maritza Novas will expose in detail the biology of cellular aging, and provide an overall view of stem cell manipulations that favor conservation and regeneration of stem cell niches to prevent or delay the affects of aging.
Dr. Karina Ravera
09:00 - 10:00
The Practical Application of Adipose Derived Stromal Vascular Fraction (SVF) in Cosmetic and Reconstructive Surgery.
CEO, Global Stem Cells Group
10:00 - 11:00
HOW TO MARKET STEM CELLS ON SOCIAL NETWORK
Mr. Novas is an entrepreneur, marketer and visionary with a proven track record in healthcare development, marketing, promotion and management, as well as demonstrated leadership skills in operations management, process improvement, and change management and quality implementation.
Dr. AGUSTI MOLINS
11:00 - 12:00
IMMUNOLOGICAL ASSAYS AS POTENCY RELEASE CRITERIA FOR MESENCHYMAL STROMAL CELLS
(MSCS) Defining the main features of human MSC and immune effector cells for testing the immune regulatory potential
• Defining the mechanisms of action that better characterize human MSC immunological properties
• Defining robust markers and assays predictive of immunological potency
• Defining the best pre-clinical research in animal models of adoptive cell therapy that provide important insights on mechanisms of action
Dr. Joseph Purita
12:00 - 13:00
In this presentation, Dr. Purita will discuss concerns over the use of PRP and stem cell injections for treatment of musculoskeletal conditions.
Dr. Purita will expand on the discussion by detailing the cutting-edge treatments he now offers to his clinic patients, including extensive use of platelet-rich plasma in conjunction with bone marrow stem cells (BMAC), adipose stem cells (SVF) and fat grafts.
Dr. Purita has broadened his clinical practice to include stem cells, until very recently thought to exist only in therapy. All components of these treatments are harvested from the patient, minimally manipulated and used the same day in keeping with FDA guidelines.
Mr. David Audley
SALES TRAINER, NAVEX GLOBAL
08:00 - 09:00
Current Regulatory Environment for Regenerative Medicine.
Learn about the current regulatory environment and how to safely, legally and ethically offer patients adult stem cell treatments in your practice.
• What are the current adult stem cell (ASC) ethics and policies?
• What are the current regulations on advanced stem cell therapies?
• What is the FDA’s involvement?
• What are the current stem cell clinical trials?
Duncan Ross PhD
09:00 - 10:00
Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis
Microvesicles, in general, and exosomes together with their delivered content in particular, are now being widely recognized as key players in atherosclerosis.
We have previously reviewed the role of microvesicles in atherosclerosis pathogenesis, diagnosis and therapy.
Here, we focus on the roles of exosomes and discuss their emergent role in mediating activation and response to inflammation, vessel infiltration and induction of coagulation. We will finally give an outlook to discuss novel detection techniques and systems biology based data analyses to investigate exosome-mediated cell-to-cell communication.
Dr. Enrique Testart
10:00 - 11:00
USE OF MSC TO ENGINEER DEVELOPMENTAL PROCESSES FOR REGENERATIVE MEDICINE
Following the exemplifying context of cartilage and bone regeneration, this lecture will describe and discuss alternative approaches to evolve classical tissue engineering paradigms towards possibly more effective grafts, with the potential for a broader clinical use.
The lecture will then propose and discuss the concept of engineering regenerative strategies by recapitulating developmental processes, exploiting the own body as the in vivo bioreactor. Rather than engineering a tissue, the strategy targets the use of cells (e.g., MSC) to engineer the different stages of a process which recapitulate events of development (e.g., endochondral ossification).
The product will be a tissue containing all necessary and sufficient cues to remodel into the target repair tissue upon grafting.
The perspective will also address issues related to scalability, process control and regulatory compliance in manufacturing cell-based products and highlight the need not only to automate, but also to streamline and simplify typical production processes
Dr. Andrea Miranda
11:00 - 12:00
A Review of New Facial Filler Techniques for Facial Rejuvenation
Over the recent years, the use of facial fillers for rejuvenation of the aging face has continued to increase in popularity. As the demand for noninvasive cosmetic enhancements increases, so does the need for new cosmetic techniques that will increase patient satisfaction while decreasing complications. In the past, facial fillers were mostly used for lip augmentation, nasolabial folds, and marionette lines.
However, because of advances in cosmetic techniques and types of dermal fillers, cosmetic surgeons today are able to correct lines, wrinkles, and volume loss seen in crow’s feet, around the eyes, chin, and cheeks.